| 40 Years of Pfs48/45 Research as a Transmission-Blocking Vaccine Target of Plasmodium falciparum Malaria. RW Sauerwein, J Plieskatt, M Theisen The American Journal of Tropical Medicine and Hygiene, tpmd211320-tpmd211320, 2022 | 7 | 2022 |
| 5. Mitochondrial DNA Haplogroups are Associated with Psychiatric Disease: A Nation-Wide Study of 74,763 Danes M Christiansen, J Bybjerg-Grauholm, C Hagen, V Gonçalves, ... Biological Psychiatry 81 (10), S3, 2017 | | 2017 |
| A flow cytometry-based workflow for detection and quantification of anti-plasmodial antibodies in vaccinated and naturally exposed individuals A Ajua, T Engleitner, M Esen, M Theisen, S Issifou, B Mordmüller Malaria Journal 11, 1-13, 2012 | 7 | 2012 |
| A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages M Theisen, W Roeffen, SK Singh, G Andersen, L Amoah, ... Vaccine 32 (22), 2623-2630, 2014 | 106 | 2014 |
| A novel Pfs38 protein complex on the surface of Plasmodium falciparum blood-stage merozoites G Paul, A Deshmukh, I Kaur, S Rathore, S Dabral, A Panda, SK Singh, ... Malaria journal 16, 1-15, 2017 | 22 | 2017 |
| A novel Pfs38 protein complex on the surface of Plasmodium falciparum blood-stage merozoites. GP Gourab Paul, AD Arunaditya Deshmukh, IK Inderjeet Kaur, ... | | 2017 |
| A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial M Alkema, MJ Smit, C Marin-Mogollon, K Totté, K Teelen, GJ van Gemert, ... BMC medicine 22 (1), 170, 2024 | 1 | 2024 |
| A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children SB Sirima, B Mordmüller, P Milligan, UA Ngoa, F Kironde, F Atuguba, ... Vaccine 34 (38), 4536-4542, 2016 | 132 | 2016 |
| A Plasmodium falciparum 48/45 single epitope R0. 6C subunit protein elicits high levels of transmission blocking antibodies SK Singh, W Roeffen, G Andersen, T Bousema, M Christiansen, ... Vaccine 33 (16), 1981-1986, 2015 | 61 | 2015 |
| A Plasmodium falciparum GLURP–MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies M Theisen, S Soe, K Brunstedt, F Follmann, L Bredmose, H Israelsen, ... Vaccine 22 (9-10), 1188-1198, 2004 | 130 | 2004 |
| A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children S Belard, S Issifou, AB Hounkpatin, F Schaumburg, UA Ngoa, M Esen, ... PloS one 6 (7), e22525, 2011 | 102 | 2011 |
| A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults AB Tiono, JL Plieskatt, A Ouedraogo, BI Soulama, K Miura, EC Bougouma, ... The Journal of Clinical Investigation 134 (7), 2024 | 3 | 2024 |
| A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine SK Singh, J Plieskatt, BK Chourasia, A Fabra-García, A Garcia-Senosiain, ... Frontiers in Immunology 11, 606266, 2021 | 24 | 2021 |
| A SYNTHETIC TLR4 AGONIST ENHANCES BI-FUNCTIONAL ANTIBODIES AND MULTI-FUNCTIONAL CD4 (+) T-CELL RESPONSES AGAINST A PLASMODIUM FALCIPARUM MULTISTAGE PROTEIN VACCINE SL Baldwin, W Roeffen, SK Singh, RW Tiendrebeogo, M Christiansen, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 93 (4), 300-301, 2015 | | 2015 |
| A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2–A GLURP–MSP3 fusion protein malaria vaccine candidate S Lousada-Dietrich, PS Jogdand, S Jepsen, VV Pinto, SB Ditlev, ... Vaccine 29 (17), 3284-3292, 2011 | 74 | 2011 |
| A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria LM Murungi, G Kamuyu, B Lowe, P Bejon, M Theisen, SM Kinyanjui, ... Vaccine 31 (37), 3936-3942, 2013 | 96 | 2013 |
| Acquisition of natural humoral immunity to P. falciparum in early life in Benin: impact of clinical, environmental and host factors C Dechavanne, I Sadissou, A Bouraima, C Ahouangninou, R Amoussa, ... Scientific reports 6 (1), 33961, 2016 | 28 | 2016 |
| Acquisition of protection to malaria correlates with patterns of antibody responses to potential vaccine antigens in children from Dielmo, Senegal [MIM-AT-74682] A Balde, A Tall, M Ndiaye, L Marrama, R Perraut, J Trape, C Rogier, ... ACTA TROPICA 95, S167-S167, 2005 | | 2005 |
| Afro-immuno assay multi-centre network project and capacity building for malaria vaccine development in Africa [MIM-DD-3468] D Dodoo, A Ocran, F Ntoumi, E Lyamuya, A Toure-balde, I Nebbie, ... ACTA TROPICA 95, S270-S271, 2005 | | 2005 |
| Analysis of the Cellular Localization of Bdr Paralogs in Borrelia burgdorferi, a Causative Agent of Lyme Disease: Evidence for Functional Diversity DM Roberts, M Theisen, RT Marconi Journal of Bacteriology 182 (15), 4222-4226, 2000 | 18 | 2000 |
